Abdollahi M, Gasparyan AY, Saeidnia S. The urge to publish more and its consequences. DARU Journal of Pharmaceutical Sciences 2014;22:53
Uncovered cases of misconduct and violation of publication ethics are increasing at rapid pace due to the digitization and open access movement in the last two decades. Large amount of funding for research, publishing and archiving activities comes from pharmaceutical agencies, supporting individuals and their research and academic institutions. These are obliged to educate their authors and to inform about publishing ethics and consequences of biased and fraudulent publications. Reviewers and science editors, in turn, have to carefully evaluate correctness of research data and transparency of authorship, contributorship, and disclosures of ethical approvals, funding, and conflicts of interests.